XNAS
ASTH
Market cap2.10bUSD
Jul 09, Last price
46.81USD
1D
1.15%
1Q
69.42%
Jan 2017
524.13%
Name
Apollo Medical Holdings Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Apollo Medical Holdings, Inc. (AMEH) is a technology-driven healthcare firm that centers its operations around its medical practitioners to deliver comprehensive healthcare solutions. The company utilizes its proprietary platform for population health management and care provisioning, running an integrated, value-focused healthcare model. This framework enables its network of practitioners to furnish comprehensive patient care. AMEH provides meticulously coordinated care for a wide array of parties, including individual patients, their relatives, general practitioners, medical specialists, acute care facilities, other inpatient settings, various physician organizations, and health insurance providers. Its clinical team includes general practitioners, specialized doctors, and hospital-based physicians. Primarily serving the California populace, it attends to patients with diverse insurance coverage—including private plans, government programs like Medicare and Medicaid, and HMOs—as well as those who are uninsured. Founded in 1994, the company maintains its corporate headquarters in Alhambra, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||